<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30254100</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-Print">            <Journal>                <ISSN IssnType="Electronic">1573-4935</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>38</Volume>                    <Issue>5</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>31</Day>                    </PubDate>                </JournalIssue>                <Title>Bioscience reports</Title>                <ISOAbbreviation>Biosci. Rep.</ISOAbbreviation>            </Journal>            <ArticleTitle>Global DNA demethylation as an epigenetic marker of human brain metastases.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">BSR20180731</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1042/BSR20180731</ELocationID>            <Abstract>                <AbstractText>Brain metastases are the most common intracranial tumors in adults. They usually originate from: lung, breast, renal cell and gastrointestinal cancers, as well as melanoma. Prognosis for brain metastases is still poor and classical treatment combining surgery and radiation therapy should be strongly supported with molecular approaches. However, their successful application depends on a deep understanding of not only genetic, but also epigenetic background of the disease. That will result in an earlier and more precise diagnosis, successful treatment, as well as individualized estimation of clinical outcomes and prognosis. It has already been shown that the epigenetic machinery plays a crucial role in cancer biology, development, and progression. Therefore, we decided to look for metastasis through changes in the most studied epigenetic mark, 5-methylcytosine (m<sup>5</sup>C) in DNA. We performed global analysis of the m<sup>5</sup>C contents in DNA isolated from the brain metastatic tumor tissue and peripheral blood samples of the same patients, using thin layer chromatography separation of radioactively labeled nucleotides. We found that the m<sup>5</sup>C level in DNA from brain metastases: changes in the broad range, overlaps with that of blood, and negatively correlates with the increasing tumor grade. Because the amount of m<sup>5</sup>C in tumor tissue and blood is almost identical, the genomic DNA methylation can be a useful marker for brain metastases detection and differentiation. Our research creates a scope for future studies on epigenetic mechanisms in neuro-oncology and can lead to development of new diagnostic methods in clinical practice.</AbstractText>                <CopyrightInformation>Â© 2018 The Author(s).</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Barciszewska</LastName>                    <ForeName>Anna-Maria</ForeName>                    <Initials>AM</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7179-1474</Identifier>                    <AffiliationInfo>                        <Affiliation>Intraoperative Imaging Unit, Chair and Clinic of Neurosurgery and Neurotraumatology, Karol Marcinkowski University of Medical Sciences, Przybyszewskiego 49, 60-355 Poznan, Poland abarcisz@man.poznan.pl.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Neurosurgery and Neurotraumatology, Heliodor Swiecicki Clinical Hospital, Przybyszewskiego 49, 60-355 Poznan, Poland.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>22</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Biosci Rep</MedlineTA>            <NlmUniqueID>8102797</NlmUniqueID>            <ISSNLinking>0144-8463</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Surg Neurol Int. 2013 May 02;4(Suppl 4):S192-202</RefSource>                <PMID Version="1">23717790</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Neurosci. 2013 Mar;53:42-51</RefSource>                <PMID Version="1">23073146</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Epigenomics. 2013 Jun;5(3):301-16</RefSource>                <PMID Version="1">23750645</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Free Radic Res. 2010 May;44(5):479-96</RefSource>                <PMID Version="1">20370557</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2011 May 27;286(21):18347-53</RefSource>                <PMID Version="1">21454628</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Genet. 2010 Nov;11(11):806-12</RefSource>                <PMID Version="1">20921961</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prog Neurol Surg. 2012;25:163-75</RefSource>                <PMID Version="1">22236678</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2001 May 1;61(9):3573-7</RefSource>                <PMID Version="1">11325821</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Dec 15;137(12):2785-94</RefSource>                <PMID Version="1">25410431</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 2010 Sep;177(3):1053-64</RefSource>                <PMID Version="1">20651229</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cureus. 2016 Apr 01;8(4):e551</RefSource>                <PMID Version="1">27182465</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2014 May 28;15(6):9519-30</RefSource>                <PMID Version="1">24879524</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2017 Jan 1;23(1):88-96</RefSource>                <PMID Version="1">27334837</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jan 17;8(3):5629-5637</RefSource>                <PMID Version="1">27895318</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2014 Nov 17;14:830</RefSource>                <PMID Version="1">25403427</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Res. 2009 Jun;19(6):959-66</RefSource>                <PMID Version="1">19273618</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Brain Tumor Pathol. 2016 Jan;33(1):1-12</RefSource>                <PMID Version="1">26496727</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuro Oncol. 2016 Aug;18(8):1043-65</RefSource>                <PMID Version="1">27382120</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2006 May 18;25(21):3059-64</RefSource>                <PMID Version="1">16407832</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Toxicology. 2011 May 10;283(2-3):65-87</RefSource>                <PMID Version="1">21414382</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Struct Mol Biol. 2013 Mar;20(3):274-81</RefSource>                <PMID Version="1">23463312</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 2007 Jan;1775(1):138-62</RefSource>                <PMID Version="1">17045745</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cold Spring Harb Perspect Biol. 2014 May 01;6(5):a019133</RefSource>                <PMID Version="1">24789823</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2012 Nov;32(11):4655-62</RefSource>                <PMID Version="1">23155227</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2016 Jan 19;18(1):8</RefSource>                <PMID Version="1">26781299</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Neuropsychopharmacol. 2016 Dec 3;19(11):</RefSource>                <PMID Version="1">27312741</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Res. 2004 Mar;2(3):196-202</RefSource>                <PMID Version="1">15037658</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2016 May 10;114(10):1101-8</RefSource>                <PMID Version="1">27100728</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Forensic Sci Int. 2015 Apr;249:255-65</RefSource>                <PMID Version="1">25732744</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Genet. 2018 Jun 7;14(6):e1007362</RefSource>                <PMID Version="1">29879107</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2016 Dec;143(3):532-538</RefSource>                <PMID Version="1">27717490</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Surg Neurol Int. 2016 Jul 07;7(Suppl 17):S488-91</RefSource>                <PMID Version="1">27512612</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Dermatol. 2014 Mar-Apr;24(2):236-41</RefSource>                <PMID Version="1">24721680</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cells. 2013 Jul 18;2(3):545-73</RefSource>                <PMID Version="1">24709797</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Epidemiol. 2012;22(5):384-94</RefSource>                <PMID Version="1">22863985</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Epigenetics. 2017 Mar 3;9:24</RefSource>                <PMID Version="1">28270869</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oxid Med Cell Longev. 2010 May-Jun;3(3):168-77</RefSource>                <PMID Version="1">20716941</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2012 Feb 1;30(4):419-25</RefSource>                <PMID Version="1">22203767</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2016 Jul;142(1):70-75</RefSource>                <PMID Version="1">27095189</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Subcell Biochem. 2013;61:597-625</RefSource>                <PMID Version="1">23150269</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Epigenetics. 2010 Dec;1(3-4):85-100</RefSource>                <PMID Version="1">22704202</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Mol Life Sci. 2009 Jul;66(14):2249-61</RefSource>                <PMID Version="1">19326048</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):655-61</RefSource>                <PMID Version="1">19942357</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Thorac Dis. 2013 Oct;5 Suppl 5:S463-78</RefSource>                <PMID Version="1">24163740</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2014 Jun;42(11):7450-60</RefSource>                <PMID Version="1">24852253</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Epigenomics. 2015;7(8):1303-11</RefSource>                <PMID Version="1">26638944</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Mar 20;9(3):e92599</RefSource>                <PMID Version="1">24651295</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Jun 09;9(6):e98464</RefSource>                <PMID Version="1">24911414</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Trends Neurosci. 2013 Aug;36(8):460-70</RefSource>                <PMID Version="1">23731492</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Oncol Rep. 2016 Dec;18(12):73</RefSource>                <PMID Version="1">27822695</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2008 Aug 03;8:222</RefSource>                <PMID Version="1">18673580</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Drug Targets. 2015;16(1):13-9</RefSource>                <PMID Version="1">25585126</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Life Sci. 2016 Mar 1;148:183-93</RefSource>                <PMID Version="1">26851532</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2012 Jan;40(Database issue):D1030-5</RefSource>                <PMID Version="1">22135302</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>FEBS Lett. 2011 Jul 7;585(13):1994-2000</RefSource>                <PMID Version="1">21056564</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Transl Res. 2015 Jan;165(1):74-90</RefSource>                <PMID Version="1">24686037</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2013 Dec 1;19(23):6404-18</RefSource>                <PMID Version="1">24298071</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2002 Jun;167(6):2419-22</RefSource>                <PMID Version="1">11992049</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncoscience. 2014 Jan 10;1(1):82-94</RefSource>                <PMID Version="1">25593989</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Biochem Cell Biol. 2016 Sep;78:288-296</RefSource>                <PMID Version="1">27474492</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jan 10;8(2):2130-2140</RefSource>                <PMID Version="1">27791985</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuro Oncol. 2017 Jan;19(1):i1-i24</RefSource>                <PMID Version="1">28031389</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Transl Lung Cancer Res. 2016 Aug;5(4):401-12</RefSource>                <PMID Version="1">27652204</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>DNA Repair (Amst). 2016 Aug;44:92-102</RefSource>                <PMID Version="1">27247237</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Med. 2016 Sep;22:32-40</RefSource>                <PMID Version="1">26837070</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Opin Pharmacol. 2010 Aug;10(4):362-8</RefSource>                <PMID Version="1">20627682</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">5-methylcytosine</Keyword>            <Keyword MajorTopicYN="N">biomarkers</Keyword>            <Keyword MajorTopicYN="N">epigenetics</Keyword>            <Keyword MajorTopicYN="N">metastasis</Keyword>            <Keyword MajorTopicYN="N">methylation</Keyword>            <Keyword MajorTopicYN="N">molecular diagnostics</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>08</Month>                <Day>20</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30254100</ArticleId>            <ArticleId IdType="pii">BSR20180731</ArticleId>            <ArticleId IdType="doi">10.1042/BSR20180731</ArticleId>            <ArticleId IdType="pmc">PMC6200709</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>